Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital Antwerpen
Edegem, Belgium
- University Hospital Leuven
Leuven, Belgium
- University Medicine Mainz
Mainz, Germany
- University Hospital Zurich
Zurich, Canton of Zurich, Switzerland
- Geneva University Hospitals
Geneva, Switzerland
- Honor Health Institute
Scottsdale, Arizona, United States
- University of Southern California
Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
- Nyu Langone Health
New York, New York, United States
- Weill Cornell Medicine
New York, New York, United States
- Duke Cancer Institute
Durham, North Carolina, United States
- University of Texas, Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jul 2019
- Primary completion
- 31 May 2025
- Completion
- 31 Aug 2025
- Last update posted
- 29 Jan 2025
- Registered enrollment
- 96
- Registry id
- NCT04046445
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.